Sattva Sukun Lifecare Intrinsic Value
SATTVASUKU Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2.10 | ₹1.68 - ₹2.52 | +200.0% | EPS: ₹0.36, Sector P/E: 12x |
| Book Value Method | asset | ₹1.75 | ₹1.57 - ₹1.93 | +150.0% | Book Value/Share: ₹12.63, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹1.40 | ₹1.26 - ₹1.54 | +100.0% | Revenue/Share: ₹35.79, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹1.40 | ₹1.26 - ₹1.54 | +100.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹2.10 | ₹1.89 - ₹2.31 | +200.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹2.10 | ₹1.89 - ₹2.31 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1.40 | ₹1.26 - ₹1.54 | +100.0% | ROE: 16.7%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹2.10 | ₹1.89 - ₹2.31 | +200.0% | EPS: ₹0.36, BVPS: ₹12.63 |
Want to compare with current market value? Check SATTVASUKU share price latest .
Valuation Comparison Chart
SATTVASUKU Intrinsic Value Analysis
What is the intrinsic value of SATTVASUKU?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sattva Sukun Lifecare (SATTVASUKU) is ₹2.10 (median value). With the current market price of ₹0.70, this represents a +200.0% variance from our estimated fair value.
The valuation range spans from ₹1.40 to ₹2.10, indicating ₹1.40 - ₹2.10.
Is SATTVASUKU undervalued or overvalued?
Based on our multi-method analysis, Sattva Sukun Lifecare (SATTVASUKU) appears to be trading below calculated value by approximately 200.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.12 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 16.7% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.52x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Sattva Sukun Lifecare
Additional stock information and data for SATTVASUKU
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-3 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-2 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |